Pages

▼
March 24, 2017

"Provectus Biopharmaceuticals Announces Terms Of Definitive Financing Commitment"

›
♢♢ Note:  I and others entered into a securities transaction with Provectus  in March 2017 . Please see the Blog's Disclosures page and...
February 13, 2017

"Intralesional rose bengal as an ablative immunotherapy for hepatic tumors"

›
Abstracts from the 26th Annual Conference of APASL (February 15th to 19th)  are available here , including that of Provectus (shown below)....
February 2, 2017

"Colon cancer cell treatment with rose bengal generates a protective immune response via immunogenic cell death"

›
Article source link is here . Click to enlarge. " Abstract: Immunotherapeutic approaches to manage patients with advanced gastr...
January 1, 2017

Rose Bengal (PV-10); The Glocalization of Cancer Treatment: "Act Locally, Think Globally"

›
Wikipedia's glocalization page notes: "Glocalization (a portmanteau of globalization and localization) is the adaptation of inte...
December 22, 2016

Rose Bengal (PV-10): HCC, Colorectal liver mets

›
Provectus issued a press release today regarding its clinical liver cancer work, "Announces Two Poster Presentations on PV-10 for Liver...
December 8, 2016

Rose Bengal (PV-10) + Oncology + Pediatrics

›
Updated below: 12/8/16 and 12/15/16. Provectus issued a press release and filed an associated 8-K today regarding a collaboration (curren...
November 23, 2016

Oncolytic

›
Source of tweet image below: Paul D. Rennert (@PDRennert). Click to enlarge On the SITC slide above, I imagine PV-10 (in combination w...